# Study of Letrozole in Recurrent Gliomas

> **NCT03122197** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Cincinnati** · enrollment: 39 (estimated)

## Conditions studied

- Brain Tumor

## Interventions

- **DRUG:** Letrozole Oral Tablet
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT03122197
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-05-16
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-12
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03122197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03122197, "Study of Letrozole in Recurrent Gliomas". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03122197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*